Literature DB >> 26640146

ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.

U-H Park1, M-R Kang2, E-J Kim3, Y-S Kwon1, W Hur4, S K Yoon4, B-J Song5, J H Park6, J-T Hwang6, J-C Jeong7, S-J Um1.   

Abstract

Estrogen receptor alpha (ERα) has a pivotal role in breast carcinogenesis by associating with various cellular factors. Selective expression of additional sex comb-like 2 (ASXL2) in ERα-positive breast cancer cells prompted us to investigate its role in chromatin modification required for ERα activation and breast carcinogenesis. Here, we observed that ASXL2 interacts with ligand E2-bound ERα and mediates ERα activation. Chromatin immunoprecipitation-sequencing analysis supports a positive role of ASXL2 at ERα target gene promoters. ASXL2 forms a complex with histone methylation modifiers including LSD1, UTX and MLL2, which all are recruited to the E2-responsive genes via ASXL2 and regulate methylations at histone H3 lysine 4, 9 and 27. The preferential binding of the PHD finger of ASXL2 to the dimethylated H3 lysine 4 may account for its requirement for ERα activation. On ASXL2 depletion, the proliferative potential of MCF7 cells and tumor size of xenograft mice decreased. Together with our finding on the higher ASXL2 expression in ERα-positive patients, we propose that ASXL2 could be a novel prognostic marker in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26640146     DOI: 10.1038/onc.2015.443

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

1.  Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors.

Authors:  Ivan Garcia-Bassets; Young-Soo Kwon; Francesca Telese; Gratien G Prefontaine; Kasey R Hutt; Christine S Cheng; Bong-Gun Ju; Kenneth A Ohgi; Jianxun Wang; Laure Escoubet-Lozach; David W Rose; Christopher K Glass; Xiang-Dong Fu; Michael G Rosenfeld
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

2.  Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer.

Authors:  Emma-Leena Alarmo; Jenita Rauta; Päivikki Kauraniemi; Ritva Karhu; Tuula Kuukasjärvi; Anne Kallioniemi
Journal:  Genes Chromosomes Cancer       Date:  2006-04       Impact factor: 5.006

3.  Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor.

Authors:  Yang-Sook Cho; Eun-Joo Kim; Ui-Hyun Park; Hong-Sig Sin; Soo-Jong Um
Journal:  J Biol Chem       Date:  2006-04-10       Impact factor: 5.157

Review 4.  Mechanisms of estrogen action.

Authors:  S Nilsson; S Mäkelä; E Treuter; M Tujague; J Thomsen; G Andersson; E Enmark; K Pettersson; M Warner; J A Gustafsson
Journal:  Physiol Rev       Date:  2001-10       Impact factor: 37.312

5.  Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer.

Authors:  Valerie Cortez; Monica Mann; Seshidhar Tekmal; Takayoshi Suzuki; Naoki Miyata; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Anil K Sood; Ratna K Vadlamudi
Journal:  Breast Cancer Res       Date:  2012-07-19       Impact factor: 6.466

6.  Mouse genome-wide association and systems genetics identify Asxl2 as a regulator of bone mineral density and osteoclastogenesis.

Authors:  Charles R Farber; Brian J Bennett; Luz Orozco; Wei Zou; Ana Lira; Emrah Kostem; Hyun Min Kang; Nicholas Furlotte; Ani Berberyan; Anatole Ghazalpour; Jaijam Suwanwela; Thomas A Drake; Eleazar Eskin; Q Tian Wang; Steven L Teitelbaum; Aldons J Lusis
Journal:  PLoS Genet       Date:  2011-04-07       Impact factor: 5.917

7.  Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state.

Authors:  Say Li Kong; Guoliang Li; Siang Lin Loh; Wing-Kin Sung; Edison T Liu
Journal:  Mol Syst Biol       Date:  2011-08-30       Impact factor: 11.429

Review 8.  Epigenetics in breast cancer: what's new?

Authors:  Yi Huang; Shweta Nayak; Rachel Jankowitz; Nancy E Davidson; Steffi Oesterreich
Journal:  Breast Cancer Res       Date:  2011-11-01       Impact factor: 6.466

9.  Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.

Authors:  Gulisa Turashvili; Jan Bouchal; Karl Baumforth; Wenbin Wei; Marta Dziechciarkova; Jiri Ehrmann; Jiri Klein; Eduard Fridman; Jozef Skarda; Josef Srovnal; Marian Hajduch; Paul Murray; Zdenek Kolar
Journal:  BMC Cancer       Date:  2007-03-27       Impact factor: 4.430

10.  Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast.

Authors:  Nuran Serce; Annette Gnatzy; Susanne Steiner; Henning Lorenzen; Jutta Kirfel; Reinhard Buettner
Journal:  BMC Clin Pathol       Date:  2012-08-24
View more
  19 in total

Review 1.  The Role of Additional Sex Combs-Like Proteins in Cancer.

Authors:  Jean-Baptiste Micol; Omar Abdel-Wahab
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

2.  A meta-analysis of transcriptome datasets characterizes malignant transformation from melanocytes and nevi to melanoma.

Authors:  Daniel Ortega-Bernal; Claudia H González-De La Rosa; Elena Arechaga-Ocampo; Miguel Angel Alvarez-Avitia; Nora Sobrevilla Moreno; Claudia Rangel-Escareño
Journal:  Oncol Lett       Date:  2018-05-31       Impact factor: 2.967

3.  ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.

Authors:  Aileen Patricia Szczepanski; Zibo Zhao; Tori Sosnowski; Young Ah Goo; Elizabeth Thomas Bartom; Lu Wang
Journal:  Genome Med       Date:  2020-07-15       Impact factor: 11.117

4.  Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.

Authors:  Shu-Yang Li; Yoichi Yoshida; Eiichi Kobayashi; Akihiko Adachi; Seiichiro Hirono; Tomoo Matsutani; Seiichiro Mine; Toshio Machida; Mikiko Ohno; Eiichiro Nishi; Yoshiro Maezawa; Minoru Takemoto; Koutaro Yokote; Kenichiro Kitamura; Makoto Sumazaki; Masaaki Ito; Hideaki Shimada; Hirotaka Takizawa; Koichi Kashiwado; Go Tomiyoshi; Natsuko Shinmen; Rika Nakamura; Hideyuki Kuroda; Xiao-Meng Zhang; Hao Wang; Kenichiro Goto; Yasuo Iwadate; Takaki Hiwasa
Journal:  Int J Mol Med       Date:  2020-07-29       Impact factor: 4.101

5.  Deferiprone: Pan-selective Histone Lysine Demethylase Inhibition Activity and Structure Activity Relationship Study.

Authors:  Verjine Khodaverdian; Subhasish Tapadar; Ian A MacDonald; Yuan Xu; Po-Yi Ho; Allison Bridges; Pragya Rajpurohit; Bhakti A Sanghani; Yuhong Fan; Muthusamy Thangaraju; Nathaniel A Hathaway; Adegboyega K Oyelere
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

Review 6.  Pharmacological Inhibition of LSD1 for Cancer Treatment.

Authors:  Guan-Jun Yang; Pui-Man Lei; Suk-Yu Wong; Dik-Lung Ma; Chung-Hang Leung
Journal:  Molecules       Date:  2018-12-04       Impact factor: 4.411

7.  Asxl2-/- Mice Exhibit De Novo Cardiomyocyte Production during Adulthood.

Authors:  Rachel Brunner; Hsiao-Lei Lai; Zane Deliu; Elan Melman; David L Geenen; Q Tian Wang
Journal:  J Dev Biol       Date:  2016-11-03

8.  Gene Regulatory Network Analysis for Triple-Negative Breast Neoplasms by Using Gene Expression Data.

Authors:  Hee Chan Jung; Sung Hwan Kim; Jeong Hoon Lee; Ju Han Kim; Sung Won Han
Journal:  J Breast Cancer       Date:  2017-09-22       Impact factor: 3.588

9.  Asxl1 exerts an antiproliferative effect on mouse lung maturation via epigenetic repression of the E2f1-Nmyc axis.

Authors:  Seungtae Moon; Sun-Kyoung Im; Nackhyoung Kim; Hyesook Youn; Ui-Hyun Park; Joo-Yeon Kim; A-Reum Kim; So-Jung An; Ji-Hoon Kim; Woong Sun; Jin-Taek Hwang; Eun-Joo Kim; Soo-Jong Um
Journal:  Cell Death Dis       Date:  2018-11-02       Impact factor: 8.469

10.  ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia.

Authors:  Jean-Baptiste Micol; Alessandro Pastore; Daichi Inoue; Nicolas Duployez; Eunhee Kim; Stanley Chun-Wei Lee; Benjamin H Durham; Young Rock Chung; Hana Cho; Xiao Jing Zhang; Akihide Yoshimi; Andrei Krivtsov; Richard Koche; Eric Solary; Amit Sinha; Claude Preudhomme; Omar Abdel-Wahab
Journal:  Nat Commun       Date:  2017-05-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.